Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.920
+0.070 (3.78%)
May 27, 2025, 2:32 PM - Market open
Heron Therapeutics Employees
Heron Therapeutics had 122 employees as of December 31, 2024. The number of employees decreased by 4 or -3.17% compared to the previous year.
Employees
122
Change (1Y)
-4
Growth (1Y)
-3.17%
Revenue / Employee
$1,217,361
Profits / Employee
-$63,811
Market Cap
292.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
HRTX News
- 19 days ago - Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025 - Seeking Alpha
- 21 days ago - Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates - PRNewsWire
- 21 days ago - Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent Litigations - PRNewsWire
- 4 weeks ago - Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer - PRNewsWire
- 4 weeks ago - Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 - PRNewsWire
- 3 months ago - Heron Therapeutics, Inc. (HRTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates - PRNewsWire